PCN101 COST-UTILITY ANALYSIS OF DASATINIB AS A SECOND-LINE...

PCN101 COST-UTILITY ANALYSIS OF DASATINIB AS A SECOND-LINE TREATMENT IN THE CHRONIC PHASE OF CHRONIC MYELOID LEUKAEMIA IN RUSSIA

S Kuznetzov, LJ Mungapen, Y Samyshkin, DE Jakouloff, U Sbarigia, M van Baardewijk
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
13
Year:
2010
Language:
english
DOI:
10.1016/s1098-3015(11)71996-9
File:
PDF, 76 KB
english, 2010
Conversion to is in progress
Conversion to is failed